Indianapolis, IN and Burlingame, CA —October 12, 2020— The Indiana University School of Medicine-Purdue TREAT-AD Center today announced that it has implemented the CDD Vault informatics platform to manage research data in the center’s Alzheimer’s disease drug development pipeline.
The TREAT-AD Center, funded by the US National Institutes of Health, is focused on developing high-quality research tools and technologies to validate and advance the next generation of drug targets for Alzheimer’s disease. CDD Vault, a hosted software developed by Collaborative Drug Discovery, Inc. (CDD), provides a secure, central storage for all chemical and biological data generated by multiple teams and projects. In addition, the center will leverage CDD Vault’s integrated electronic lab notebook and API for the organization, analysis, and sharing of results within the group and with external partners.
“After reviewing several database solutions for managing the center’s drug discovery data, including open-source options and building our own, CDD Vault became the clear choice for its simplicity, effectiveness and overall costs,” said Timothy Richardson, PhD, senior research professor of medicine at IU School of Medicine and leader of the Medicinal Chemistry and Chemical Biology Core for the TREAT-AD Center. “CDD Vault will play a key role in the IU School of Medicine-Purdue TREAT-AD Center’s comprehensive database management plan moving forward.”
“Alzheimer’s disease is a major healthcare challenge in today’s world,” said Barry Bunin, PhD, CEO of CDD, “We are excited that the TREAT-AD Center has chosen CDD Vault as their informatics infrastructure and look forward to supporting this important initiative.”
IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.
CDD’s (www.collaborativedrug.com) flagship product, “CDD Vault®”, is used to manage chemical registration, structure-activity relationships (SAR), and securely scale collaborations. CDD Vault® is a hosted database solution for secure management and sharing of biological and chemical data. It lets you intuitively organize chemical structures and biological study data, and collaborate with internal or external partners through an easy to use web interface. Available modules within CDD Vault include Activity & Registration, Visualization, Inventory, and ELN.
A complete list of more than 60 publications and patents from CDD can be found online on our resources page at https://www.collaborativedrug.com/publications-and-resources/.
Media Contact: Barry Bunin, Ph.D., Collaborative Drug Discovery, marketing@collaborativedrug.com.